Olympus Recalls Disposable Triple Lumen Sphincterotome Due to Potential Deformation and Performance Loss
According to the U.S. Census Bureau's American Community Survey (ACS) 5-year estimates, the CDC PLACES population-level health analysis, and the CMS Hospital Compare quality data, Areazine publishes editorial articles drawing on more than 19,000 U.S. city profiles. See our methodology for full source attribution and refresh cadence.
Olympus Corporation of the Americas has issued a voluntary recall for its Disposable Triple Lumen Sphincterotome after discovering manufacturing defects that could cause the device to deform.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on February 18, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken — "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to — FDA Recalls — determines the regulatory framework behind it, which shapes what remedies (refunds, replacements, recalls, evacuations) are available to affected individuals and who holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to read it as a data point about the issuing system: how quickly FDA detected the hazard, how precise the geographic or product-identifier scope is, and whether similar notices have clustered in the same category or region in the last 90 days. Cluster patterns frequently precede a broader regulatory action — a single localized FDA recall is isolated; three of them within a quarter often indicate a supply-chain, infrastructure, or seasonal driver that will keep producing notices until something structural changes.
For decision-making, Areazine pairs each alert with the original agency URL, the full agency name, and a timestamp so you can verify the notice against the primary source before acting on it. Tags on this item (recall, product-safety, fda, MedicalDevice) map to related alerts in the same area of risk — browsing them together gives a clearer picture than any single notice alone, because the shape of an ongoing issue only becomes visible across multiple sequential alerts.
What Happened
Olympus Corporation of the Americas has initiated a voluntary recall of its Disposable Triple Lumen Sphincterotome. The recall was prompted by the discovery that certain devices did not undergo a necessary thermoforming process during manufacturing. As a result, these instruments could deform and lose performance during medical procedures.
Which Products Are Affected
The recall involves the following medical device:
- Brand Name: Disposable Triple Lumen Sphincterotome
- Model/Catalog Number: KD-401Q-0320
- Material REF: 5856630
- UDI-DI: 04953170041587
- Affected Lots: All lots with a valid expiration date
- Quantity: 999 units
These instruments are designed for use with an Olympus endoscope and guidewire for papillotomy using high-frequency current. The distribution of these products is worldwide, including nationwide distribution across the United States in 44 states, the District of Columbia, and Guam.
What You Should Do
Olympus initiated the recall notification via letter on January 7, 2026. Healthcare facilities and providers should immediately check their inventory for the affected model number (KD-401Q-0320). If affected units are found, users should follow the specific instructions provided in the firm's notification letter regarding the handling and return of the devices. For further information, facilities may contact Olympus Corporation of the Americas at their Center Valley, PA headquarters.
Why This Matters
This recall is classified as a Class II event by the FDA. Because these devices are used in surgical procedures involving high-frequency current, any deformation or loss of performance could lead to complications during the papillotomy, potentially impacting patient safety and procedural success.
Source
This information is based on official recall data provided by the FDA under recall number Z-1293-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.
What is this FDA recall about? ▾
Which agency issued this alert? ▾
How severe is this alert? ▾
What area is affected? ▾
Where can I find more FDA Recalls updates? ▾
Primary source data
EPA Outdoor Air Quality Data
Federal monitoring network — every measurement we report
AirNow (EPA / NOAA)
Real-time AQI for every monitored U.S. location
National Weather Service
Active watches, warnings, and advisories — NOAA
CDC Air Quality & Health
Health-impact reference behind every AQI category